Lily Allen is so back. The singer-songwriter, known for 2000s hits like “Smile” and “The Fear,” just released her first album in seven years, West End Girl—and she’s not holding back. This not only ...

Eli Lilly stock (NYSE: LLY) is up 10% this month, a rise driven by strong clinical trial progress. This includes the announcement of positive Phase 3 results in October 2025 for its oral GLP-1 drug, ...

Eli Lilly (NYSE:LLY) on Friday reported plans to acquire Adverum Biotechnologies (NASDAQ:ADVM) and its lead gene therapy candidate, Ixo-vec, sending Adverum shares soaring in premarket trading. Under ...

Lavendaire shares night routines for skincare and stretching to wind down and recharge. Prop 50 California results so far ‘Predator: Badlands’ early reviews are all leaning one way Video footage ...

One couple was changed for good during “Dancing With the Stars” Wicked Night. The Oct. 21 episode welcomed director John M. Chu as the guest judge as pairs danced to hit songs from “Wicked” — with ...

Though Novo Nordisk had a first-mover advantage in the GLP-1 market, Eli Lilly is catching up. Lilly's recent clinical progress sets it up for another critical approval. The company has fantastic ...

Eli Lilly is calling on European countries to make “urgent improvements” to their Alzheimer’s disease diagnostic testing practices just weeks after nabbing a new approval on the continent for its ...

In 1974, photographer Edie Baskin met Lorne Michaels at a poker game at the Chateau Marmont in Los Angeles. The two became fast friends, and, not long after, they started talking about working ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — Riding high on the success of its blockbuster weight loss drug, Eli ...

Eli Lilly LLY0.12%increase; green up pointing triangle said it plans to build a $6.5 billion facility in Houston to make active pharmaceutical ingredients, including for a new oral weight-loss drug.